Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789021 | 0.84 | ALDH1A1 (0.55) | ALDH1A1SLC1A1CA1CA2CA7 | |
| SCHEMBL25391226 | 0.81 | APOBEC3A (0.37) | ALDH1A1SLC1A1CA1CA2CA7 | |
| Iodide SCHEMBL25391622 | 0.80 | APOBEC3A (0.36) | ALDH1A1SLC1A1CA1CA2CA7 | |
| SCHEMBL25391233 | 0.80 | RGS12 (0.39) | SLC1A1CA1CA2CA7CA9 | |
| Iodide SCHEMBL25391625 | 0.80 | RGS12 (0.41) | CA1CA2CA7CA9APOBEC3A | |
| SCHEMBL11657250 | 0.79 | CA1 (0.53) | ALDH1A1SLC1A1CA1CA2CA7 | |
| SCHEMBL10834752 | 0.79 | ALDH1A1 (0.49) | ALDH1A1SLC1A1CA1CA2CA7 | |
| SCHEMBL391732 | 0.79 | APOBEC3A (0.49) | ALDH1A1SLC1A1CA1CA2CA7 | |
| SCHEMBL24827422 | 0.79 | ALDH1A1 (0.57) | ALDH1A1SLC1A1CA1CA2CA7 | |
| SCHEMBL6385004 | 0.78 | SMN1; SMN2 (0.44) | ALDH1A1TSHRHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10251841-B2 | Polymeric depots for localization of agent to biological sites | TRUSTEES OF BOSTON UNIVERSITY (US) | 2019-04-09 | — | — | US | disclosed |
| WO-2018041132-A1 | MONOMER, POLYMER, PREPARATION METHOD THEREFOR AND USE THEREOF | 广东东阳光药业有限公司 | 2018-03-08 | — | — | WO | disclosed |
| US-20140271489-A1 | POLYMERIC DEPOTS FOR LOCALIZATION OF AGENT TO BIOLOGICAL SITES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130195954-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130195954-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130195954-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2013-08-01 | — | — | US | disclosed |
| US-8338492-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-12-25 | — | — | US | disclosed |
| US-8338492-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-12-25 | — | — | US | disclosed |
| US-8338492-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-12-25 | — | — | US | disclosed |
| US-8334324-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-12-18 | — | — | US | disclosed |
| US-20120107365-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-05-03 | — | — | US | disclosed |
| US-20110152305-A1 | FILMS AND PARTICLES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20110152305-A1 | FILMS AND PARTICLES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20110152305-A1 | FILMS AND PARTICLES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-7671095-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671095-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671095-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2010-03-02 | — | — | US | disclosed |
| US-20080075718-A1 | Films and Particles | THE TRUSTEES OF THE BOSTON UNIVERSITY | 2008-03-27 | — | — | US | disclosed |
| US-20080075718-A1 | Films and Particles | THE TRUSTEES OF THE BOSTON UNIVERSITY | 2008-03-27 | — | — | US | disclosed |
| US-20080075718-A1 | Films and Particles | THE TRUSTEES OF THE BOSTON UNIVERSITY | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152305-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | ALDH1A1 2505/4885SLC1A1 4813/4885CA1 3355/4885 |
| US-10251841-B2 | Polymeric depots for localization of agent to biological sites | CD68, LPXN, CXCL12 | ALDH1A1 3186/4885SLC1A1 4167/4885CA1 2868/4885 |
| US-20130195954-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | ALDH1A1 2505/4885SLC1A1 4813/4885CA1 3355/4885 |
| US-20080075718-A1 | Films and Particles | APOB, PGF, ACTB | ALDH1A1 2505/4885SLC1A1 4813/4885CA1 3355/4885 |
| US-20140271489-A1 | POLYMERIC DEPOTS FOR LOCALIZATION OF AGENT TO BIOLOGICAL SITES | CD68, LPXN, CXCL12 | ALDH1A1 3186/4885SLC1A1 4167/4885CA1 2868/4885 |
| US-20120107365-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | ALDH1A1 2505/4885SLC1A1 4813/4885CA1 3355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.